Andrew Zloza
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 11, 2023
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.Sachin R Jhawar, Shang-Jui Wang, Aditya Thandoni
|May 31, 2019
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma.Praveen K Bommareddy, Andrew Zloza, Samuel D Rabkin
|May 24, 2019
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.Mark N Stein, Jyoti Malhotra, Rohinton S Tarapore
|May 21, 2015
NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.Frederick J Kohlhapp, Joseph R Broucek, Tasha Hughes
Pageof 1
